Healthcare :: Residents urged to register for fair pharmacare
The provincial government is encouraging all British Columbians and their families to register for Fair PharmaCare if they have not done so already.
Arthritis :: CDc presents first state–by–state data on work limitations caused by arthritis
Work limitation due to arthritis in all working–age adults ranges from a low of 3.4 percent in Hawaii to a high of 15 percent in Kentucky, according to a Centers for Disease Control and Prevention (CDC) study that provides the first ever state–by–state data on adults experiencing work limitations caused by arthritis.
Lead :: CTFA statement on lead in lipstick
Lead is a naturally occurring element that is found everywhere in the environment. Following is the statement by John Bailey, EVP for science cosmetic, toiletry, and fragrance association on campaign for safe cosmetics report on lead in lipstick –
Health :: Conversation on health ends with record participation
The final numbers are in. The Conversation on Health has ended, with over 12,000 submissions and thousands more people taking part in public forums, providing their ideas on the future of the health system.
Nutrition :: ACTNOW BC Nutrition campaign launched
A new campaign encouraging British Columbians to eat “just one more” fruit and veggie serving was launched today at Granville Island Market by Gordon Hogg, Minister of State for ActNow BC.
Almond Allergy :: Winn-Dixie stores recall mislabeled prestige chocolate ice cream
Winn-Dixie Stores, Inc. is recalling one code of its 1.75 quart (1.65 liter) cartons of “Prestige Chocolate Ice Cream” because of a potential error in packaging. Some of the products may have the correct lid identifying the product as chocolate almond, but the “tub” is identified as only chocolate.
Health :: B.C. invests in provincial patient safety initiative
Government has invested $2.3 million towards development of a provincewide patient safety learning system based on the success of pilot-testing at two B.C. hospitals, announced Health Minister George Abbott during Canadian Patient Safety Week.
Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS
Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September_26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the company’s potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS).
Testosterone :: Study finds that even aloof husbands have lower testosterone levels than unmarried men
A fascinating new study is the first outside of North America to observe lower testosterone levels among married men. Supporting a growing body of research, the study reveals that even married men who are considered aloof spouses and provide minimal parenting have much lower testosterone levels than single, unmarried men.
Cough :: Withdrawal of oral cough and cold medicines in Canada
Members of the Nonprescription Drug Manufacturers Association of Canada announced the voluntary withdrawal of oral cough and cold medicines intended for use in children under the age of two years. The withdrawal is a highly cautionary response to rare patterns of misuse identified during the course of a review of safety data related to children’s cough and cold medicines.